Kennedy Institute of Rheumatology, Imperial College London, UK
Professor Feldmann’s interests focus on molecular mechanisms of autoimmune diseases, with a special interest in the role of cytokines in disease.
These interests range from gene regulation of cytokines, how innate and adaptive immune responses intersect via NFkB, TLR and cytokines, and extends to novel therapeutic approaches for autoimmune or other diseases.
His work has the long-term intent of helping develop new therapies, so called translational research.
Professor Feldmann’s work has led to new treatments for rheumatoid arthritis based on the blocking of TNFα.